A pharmacometrics model to define docetaxel target in early breast cancer
Aims: We aimed to study the relation between pharmacokinetics (PK) and pharmacodynamics (PD) of docetaxel in early breast cancer and recommend a target exposure. Methods: A PK/PD study was performed in 27 early breast cancer patients treated with doxorubicin and cyclophosphamide for 4 cycles foll...
| Päätekijät: | , , |
|---|---|
| Aineistotyyppi: | info:eu-repo/semantics/article |
| Kieli: | eng |
| Julkaistu: |
Wiley
2023
|
| Aiheet: | |
| Linkit: | https://hdl.handle.net/10171/66083 |